GSK’s RSV vaccine shows positive data on efficacy in older adults
HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 21, 2023: British pharmaceutical company, GSK Plc’s vaccine against the respiratory syncytial virus has shown positive data on its efficacy.
GSK races ahead of rivals Pfizer and Moderna in getting FDA approval for RSV vaccine.